MedPath

NEURODEVELOPMENTAL OUTCOME OF HIGH RISK NEONATES

Not yet recruiting
Conditions
Attention-deficit hyperactivity disorder, predominantly inattentive type,
Registration Number
CTRI/2023/08/055981
Lead Sponsor
Not applicable
Brief Summary

Every new born baby has to go through a complex process of growth and

development at various levels to ultimately emerge as a normal adult. Any

deviation in these stages of development will lead to developmental disability.

Such disability may express in various forms, which include mental retardation,

cerebral palsy, autism, attention deficit disorders, visual and hearing problems,

speech and language disorders, learning disabilities and many more. These

problems increase as birth weight decreases. Impaired neurodevelopmental

outcome is a major long-term complication of surviving premature infants,

especially extremely premature infants who are born at or below 32 weeks

gestation.1-2 Sick neonates, particularly preterm babies, very low birth weight

(VLBW) and extremely low birth weight (ELBW) babies (birth weights less

than 1500 and 1000 g respectively) with perinatalhypoxia and

hypoxic-ischaemic encephalopathy, sepsis, severe jaundice, etc. are most

vulnerable to poor neuro-developmental outcome.3These are classified as high

risk infants.

 Insult to the developing brain may lead to gross and fine structural

changes resulting in smaller brain size, reduced white and grey matter,

ventriculomegaly, decreased callosal projections and altered fibre tract

organization, which eventually affects neural function.4 Hence, a close

neuro-developmental follow-up of these high-risk newborns is essential for

early detection of any brain damage, to prevent or restrict a poor

neuro-developmental outcome through early intervention.

Intrauterine and neonatal insults substantially affect the global burden of

disease, measured in disability-adjusted life-years, because they contribute to

both premature mortality and long-term disability.5 However, little is known

about the severity and distribution of long-term impairments after intrauterine or

neonatal insults. As a result, sequelae from intrauterine and neonatal insults

have not been adequately captured in estimates of the global burden of

disease.6,7

In India, unfortunately, there is not enough awareness about the

abovementioned facts and that neurodevelopment assessment has long been

considered the domain of pediatric neurologist, and general paediatricians often

fail to recognize the delay that had begun to set in the neonatal intensive care

unit (NICU) graduate that had come to him for various medical problems.

Though perinatal and newborn care is improving in rural India, a section of the

rural population is still deprived of all the available facilities, due to

socio-economic, cultural and topographical reasons. There is very scanty data

from this part of the globe, regarding neuro-devel-opmental outcome of high

risk newborns and the magnitude of the problem of evolving developmental

challenges, hence we remain oblivious of the gravity of the situation. This

opportunity is big one to miss because, it was at this point, if early intervention

done to modify social and psychosocial environment of the infant would have

made a large difference to his eventual neurodevelopment outcome.​

Recognition of precipitating factors and adequate preventive measures,

detection of early markers of developmental delay and early intervention

measures can go a long way in preventing childhood disability.8 This calls in for

a neuro-developmental follow-up of high risk babies by a specialized team,

using proper scientific methodology.9

  With this background, we will venture to follow up high risk babies discharged

from the Tertiary Newborn Care unit at wardha, a district of Maharashtra, India

to study the prevalence of delayed development in high risk babies and identify

their various aetiological factors and associations. Simultaneous provision of

early intervention will also initiated as a preventive and therapeutic measure.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria
  • o High risk babies discharged from Neonatal intensive care unit.
  • o Patients of babies giving consent for the Study.
Exclusion Criteria
  • o Babies born with gross Congenital Malformations and syndromes o Drop outs and failure to follow up from the study.[if followed less than three visits out of four visits] o Parents not giving consent for the study.
  • o Babies with major congenital heart diseases.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study prevalence of neurodevelopmental delay of high risk babies.2 years
2.To study neurodevelopmental outcome in relation to gestational age at birth.2 years
Secondary Outcome Measures
NameTimeMethod
3.To study neurodevelopmental outcome in relation to birth weight.

Trial Locations

Locations (1)

Datta meghe institute of higher education and research

🇮🇳

Wardha, MAHARASHTRA, India

Datta meghe institute of higher education and research
🇮🇳Wardha, MAHARASHTRA, India
Dr Anuja Handargule
Principal investigator
9619113984
anujahandargule@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.